AVAX Technologies, Inc.
AVAX Technologies, Inc. (AVXT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AVXT · as of Jun 9, 2026
Key Statistics
Explore AVAX Technologies, Inc. Data
avxt stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
avxt competitorsAVXT
BRAXF
DNAG
INLB
IPAH
JNHMFStock Performance
Full HistoryAbout AVAX Technologies, Inc.
AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on pioneering autologous cell vaccine methods for cancer therapy. Its pipeline includes lead candidates M-VAX, for melanoma, an…
what is avax technologies, inc. · avxt stock overview · avax technologies, inc. company profile · who is avax technologies, inc. ceo · avxt OTC · avax technologies, inc. headquarters · avax technologies, inc. business segments
About Stock Overview & Key Data
AVAX Technologies, Inc. (AVXT) is a Healthcare company in the Biotechnology industry, listed on OTC since May 15, 1997. As of the latest trading session, AVXT stock price is $0.00, with a market capitalization of $6,894. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2007, AVAX Technologies, Inc. reported revenue of $617384.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AVAX Technologies, Inc. (AVXT) stock price is $0.00. The stock is traded on OTC under the ticker symbol AVXT. The 52-week range is $0.00 – $0.00.